Jasmin Asberger

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

The impact of the patient macroenvironment on molecular subgroups in endometrial cancer.

The impact of the patient macroenvironment on molecular subgroups in endometrial cancer.

Journal: Cancer

Published: December 10, 2025

Surgical stage in the era of molecular profiling of endometrial cancer.

Surgical stage in the era of molecular profiling of endometrial cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 03, 2025

ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.

ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 06, 2025

Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma.

Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 06, 2025

Real-World Data Analysis of CDK4/6 Inhibitor Therapy-A Patient-Centric Single Center Study.

Real-World Data Analysis of CDK4/6 Inhibitor Therapy-A Patient-Centric Single Center Study.

Journal: Cancers

Published: March 29, 2024

Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.

Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.

Journal: Gynecologic oncology

Published: December 04, 2023

Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?

Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?

Journal: Experimental and therapeutic medicine

Published: August 27, 2023

In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer.

In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer.

Journal: Biomedicines

Published: July 25, 2023

Treatment of Cesarean Scar and Cervical Pregnancies Using the Ovum Aspiration Set for Intrachorial Methotrexate Injection as a Conservative, Fertility-Preserving Procedure.

Treatment of Cesarean Scar and Cervical Pregnancies Using the Ovum Aspiration Set for Intrachorial Methotrexate Injection as a Conservative, Fertility-Preserving Procedure.

Journal: Medicina (Kaunas, Lithuania)

Published: March 11, 2023

[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer.

[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer.

Journal: Archives of gynecology and obstetrics

Published: February 07, 2023

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer.

Journal: JAMA network open

Published: December 16, 2022

Gastrin-Releasing Peptide Receptor Antagonist [68Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer.

Gastrin-Releasing Peptide Receptor Antagonist [68Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer.

Journal: Cancers

Published: November 03, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026